Carboanhydrase-IX-Hemmer

Patent europeic · EP2240171 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2240171
Numer da la dumonda
EP09701293
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
08-01-2009
Publitgà
20-10-2010
Concedì
13-08-2014
Stritgà
31-01-2015
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/18 (2006.01)
A61K 31/4192 (2006.01)
A61K 31/444 (2006.01)
A61K 51/04 (2006.01)
A61P 35/00 (2006.01)
A61K 31/555 (2006.01)
Prioritad
US 20043 P 09.01.2008
US 88980 P 14.08.2008
US 142002 P 31.12.2008
Dumonda PCT
PCT/US2009/030487 08.01.2009
Publicaziun PCT
WO2009/089383 16.07.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-08-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.08.2015

  2. 13-08-2014

    Concedì

    Published in Swissreg on 13.08.2014

Partidas

Possessur

Molecular Insight Pharmaceuticals, Inc.

160 Second Street, Cambridge, MA 02142, US

Inventur

ZIMMERMAN, Craig

Topsfield, MA 01983, US

BABICH, John, W.

Cambridge, MA 02142, US

JOYAL, John

Melrose, MA 02176, US

LU, Genliang

Winchester, MA 01890, US

MARESCA, Kevin, P.

Tewksbury, MA 01876, US

BARONE, Chris

Roxbury Crossing, MA 02120, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.